Olodaterol

No registered brands found for this active ingredient.

No food notes on record for this active ingredient.

• EtrasimodMAJOR

  The risk or severity of QTc prolongation and torsade de pointes can be increased when Etrasimod is combined with Olodaterol.

  Expert view
• (R)-warfarinMODERATE

  The metabolism of Olodaterol can be decreased when combined with (R)-warfarin.

  Expert view
• 1-benzylimidazoleMODERATE

  The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Olodaterol.

  Expert view
• 2,5-Dimethoxy-4-ethylamphetamineMODERATE

  The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Olodaterol.

  Expert view
• 3-isobutyl-1-methyl-7H-xanthineMODERATE

  3-isobutyl-1-methyl-7H-xanthine may increase the hyperkalemic activities of Olodaterol.

  Expert view
• 4-Bromo-2,5-dimethoxyamphetamineMODERATE

  The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Olodaterol.

  Expert view
• 4-MethoxyamphetamineMODERATE

  The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Olodaterol.

  Expert view
• 7-DeazaguanineMODERATE

  7-Deazaguanine may increase the hyperkalemic activities of Olodaterol.

  Expert view
• 7,8-Dichloro-1,2,3,4-tetrahydroisoquinolineMODERATE

  The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Olodaterol.

  Expert view
• 7,9-DimethylguanineMODERATE

  7,9-Dimethylguanine may increase the hyperkalemic activities of Olodaterol.

  Expert view